Epigenetic regulation of SOD2 and CFH gene expression in the aging RPE

衰老 RPE 中 SOD2 和 CFH 基因表达的表观遗传调控

基本信息

项目摘要

DESCRIPTION (provided by applicant): Age-related macular degeneration (AMD) is a complex disease where multiple nongenetic and genetic risk factors lead to disease development in an age-related fashion. Aging and cigarette smoking are the clearest examples of nongenetic risk factors, and both have been linked to elevated levels of oxidative stress. Genetic risk factors include a set of variant alleles for genes in the alternative complement pathway, among others. One of the fundamental objectives in AMD research is to understand how nongenetic factors are integrated with the genetic basis of this disease. The epigenetic regulation of the genome is currently thought to be the molecular mechanism through which nongenetic factors have an effect. In this application, we propose to study the age-related epigenetic regulation of wild type alleles of manganese superoxide dismutase (SOD2) and complement factor H (CFH), two genes whose variant alleles are associated with the risk of AMD. SOD2 is the major source of cytosolic hydrogen peroxide which leads to oxidative stress in the retinal pigment epithelium (RPE), and its expression is epigenetically regulated. CFH is a major inhibitor of the alternative complement pathway, whose expression is regulated by oxidative stress at the transcriptional level and epigenetically through miR-146a at the translational level. We hypothesize that nongenetic mechanisms regulating the expression of the wild type alleles of SOD2 and CFH lead to an alteration of protein concentration, which is similar to changes of function for the gene products of the mutant alleles. The significance of this work rests in a hypothesis which integrates genetics, environmental effects, and aging. Approaching the pathogenesis of AMD in this fashion may lead to new clinical approaches for better management or even prevention of the disease.
描述(由申请人提供):视网膜相关性黄斑变性(AMD)是一种复杂的疾病,其中多种非遗传和遗传风险因素以与年龄相关的方式导致疾病发展。衰老和吸烟是最明显的非遗传风险因素的例子,两者都与氧化应激水平升高有关。遗传风险因素包括补体旁路途径中基因的一组变异等位基因等。AMD研究的基本目标之一是了解非遗传因素如何与这种疾病的遗传基础相结合。基因组的表观遗传调控目前被认为是非遗传因素发挥作用的分子机制。在本申请中,我们提出研究锰超氧化物歧化酶(SOD 2)和补体因子H(CFH)的野生型等位基因的年龄相关的表观遗传调节,这两个基因的变体等位基因与AMD的风险相关。SOD 2是导致视网膜色素上皮细胞(RPE)中氧化应激的细胞溶质过氧化氢的主要来源,其表达受表观遗传学调节。CFH是补体旁路途径的主要抑制剂,其表达在转录水平上受氧化应激调节,在翻译水平上通过miR-146 a表观遗传学调节。我们推测,非遗传机制调节的野生型等位基因的SOD 2和CFH的表达导致蛋白质浓度的改变,这是类似的突变等位基因的基因产物的功能的变化。这项工作的意义在于一个假设,它整合了遗传学,环境影响和衰老。以这种方式接近AMD的发病机制可能会导致新的临床方法,以更好地管理甚至预防该疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Leonard Martin Hjelmeland其他文献

Leonard Martin Hjelmeland的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Leonard Martin Hjelmeland', 18)}}的其他基金

Epigenetic regulation of SOD2 and CFH gene expression in the aging RPE
衰老 RPE 中 SOD2 和 CFH 基因表达的表观遗传调控
  • 批准号:
    8538398
  • 财政年份:
    2011
  • 资助金额:
    $ 58.86万
  • 项目类别:
Epigenetic regulation of SOD2 and CFH gene expression in the aging RPE
衰老 RPE 中 SOD2 和 CFH 基因表达的表观遗传调控
  • 批准号:
    8085950
  • 财政年份:
    2011
  • 资助金额:
    $ 58.86万
  • 项目类别:
EPIGENETIC AGING OF THE OXIDATIVE STRESS RESPONSE IN THE MOUSE RPE
小鼠 RPE 氧化应激反应的表观遗传老化
  • 批准号:
    7986159
  • 财政年份:
    2010
  • 资助金额:
    $ 58.86万
  • 项目类别:
Age-related epigenetic gene silencing in the RPE
RPE 中与年龄相关的表观遗传基因沉默
  • 批准号:
    7138505
  • 财政年份:
    2006
  • 资助金额:
    $ 58.86万
  • 项目类别:
Age-related epigenetic gene silencing in the RPE
RPE 中与年龄相关的表观遗传基因沉默
  • 批准号:
    7270099
  • 财政年份:
    2006
  • 资助金额:
    $ 58.86万
  • 项目类别:
REDOX CONTROL OF FGF GENE EXPRESSION IN AGING RPE
衰老 RPE 中 FGF 基因表达的氧化还原控制
  • 批准号:
    6384530
  • 财政年份:
    1986
  • 资助金额:
    $ 58.86万
  • 项目类别:
BIOCHEMICAL MODULATION OF RETINAL GLIOSIS
视网膜胶质细胞增生的生化调节
  • 批准号:
    3262655
  • 财政年份:
    1986
  • 资助金额:
    $ 58.86万
  • 项目类别:
REGULATION OF FGF EXPRESSION DURING RETINAL DETACHMENT
视网膜脱离过程中 FGF 表达的调节
  • 批准号:
    2710920
  • 财政年份:
    1986
  • 资助金额:
    $ 58.86万
  • 项目类别:
BIOCHEMICAL MODULATION OF RETINAL GLIOSIS
视网膜胶质细胞增生的生化调节
  • 批准号:
    3262656
  • 财政年份:
    1986
  • 资助金额:
    $ 58.86万
  • 项目类别:
REGULATION OF FGF EXPRESSION DURING RETINAL DETACHMENT
视网膜脱离过程中 FGF 表达的调节
  • 批准号:
    3262654
  • 财政年份:
    1986
  • 资助金额:
    $ 58.86万
  • 项目类别:

相似海外基金

I(eye)-SCREEN: A real-world AI-based infrastructure for screening and prediction of progression in age-related macular degeneration (AMD) providing accessible shared care
I(eye)-SCREEN:基于人工智能的现实基础设施,用于筛查和预测年龄相关性黄斑变性 (AMD) 的进展,提供可及的共享护理
  • 批准号:
    10102692
  • 财政年份:
    2024
  • 资助金额:
    $ 58.86万
  • 项目类别:
    EU-Funded
Inhibiting Neovascularization and Subretinal Fibrosis in Neovascular Age-Related Macular Degeneration
抑制新生血管性年龄相关性黄斑变性的新生血管形成和视网膜下纤维化
  • 批准号:
    10639785
  • 财政年份:
    2023
  • 资助金额:
    $ 58.86万
  • 项目类别:
Inhibition of melanogenesis in retinal pigment epithelium, a contributing factor in age-related macular degeneration
抑制视网膜色素上皮中的黑色素生成,这是年龄相关性黄斑变性的一个促成因素
  • 批准号:
    23K09052
  • 财政年份:
    2023
  • 资助金额:
    $ 58.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
  • 批准号:
    10679287
  • 财政年份:
    2023
  • 资助金额:
    $ 58.86万
  • 项目类别:
Evaluation of New Anti-inflammatory Treatments for Age-Related Macular Degeneration
年龄相关性黄斑变性的新型抗炎治疗方法的评价
  • 批准号:
    10642988
  • 财政年份:
    2023
  • 资助金额:
    $ 58.86万
  • 项目类别:
Progression of Early Atrophic Lesions in Age-related Macular degeneration
年龄相关性黄斑变性早期萎缩性病变的进展
  • 批准号:
    10635325
  • 财政年份:
    2023
  • 资助金额:
    $ 58.86万
  • 项目类别:
Cellular and molecular mechanisms of AIM2 and NLRP3 inflammasome activation in age-related macular degeneration
年龄相关性黄斑变性中 AIM2 和 NLRP3 炎症小体激活的细胞和分子机制
  • 批准号:
    10584110
  • 财政年份:
    2023
  • 资助金额:
    $ 58.86万
  • 项目类别:
Elucidation of roles of mast cells and macrophages in the pathogenesis of age-related macular degeneration
阐明肥大细胞和巨噬细胞在年龄相关性黄斑变性发病机制中的作用
  • 批准号:
    22H03243
  • 财政年份:
    2022
  • 资助金额:
    $ 58.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
AMD Mitochondria Modulate Expression of microRNA 135b-5p and 148a-3p in RPE Cybrids: Implications for Age-related Macular Degeneration
AMD 线粒体调节 RPE Cybrids 中 microRNA 135b-5p 和 148a-3p 的表达:对年龄相关性黄斑变性的影响
  • 批准号:
    10433610
  • 财政年份:
    2022
  • 资助金额:
    $ 58.86万
  • 项目类别:
Targeting the inflammatory response in age-related macular degeneration
针对年龄相关性黄斑变性的炎症反应
  • 批准号:
    10504138
  • 财政年份:
    2022
  • 资助金额:
    $ 58.86万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了